Eytan BREMAN

Person

Mont-Saint-Guibert, BE

People

Patents Grantslast 30 patents

Information Patent Grant
Reducing fratricide of immune cells expressing NKG2D-based receptors
- Patent number 11,639,496
- Issue date May 2, 2023
- CELYAD S.A.
- David Gilham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NKG2D CAR CELLS EXPRESSING IL-18 FOR ADOPTIVE CELL THERAPY
- Publication number 20240366668
- Publication date Nov 7, 2024
- CELYAD ONCOLOGY S.A.
- Eytan BREMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS
- Publication number 20230348855
- Publication date Nov 2, 2023
- CELYAD S.A.
- David GILHAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED SCAFFOLDS FOR MULTIPLEXED INHIBITORY RNA
- Publication number 20230159928
- Publication date May 25, 2023
- CELYAD ONCOLOGY S.A.
- Mikhail STEKLOV
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD52-DEFICIENT CELLS FOR ADOPTIVE CELL THERAPY
- Publication number 20220313737
- Publication date Oct 6, 2022
- CELYAD ONCOLOGY S.A.
- Simon BORNSCHEIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS WITH MULTIPLEXED INHIBITORY RNA
- Publication number 20220202863
- Publication date Jun 30, 2022
- Simon BORNSCHEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS
- Publication number 20200318067
- Publication date Oct 8, 2020
- CELYAD S.A.
- David GILHAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Eytan BREMAN

Person

Patents Grantslast 30 patents

Reducing fratricide of immune cells expressing NKG2D-based receptors

Patents Applicationslast 30 patents

NKG2D CAR CELLS EXPRESSING IL-18 FOR ADOPTIVE CELL THERAPY

REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS

IMPROVED SCAFFOLDS FOR MULTIPLEXED INHIBITORY RNA

CD52-DEFICIENT CELLS FOR ADOPTIVE CELL THERAPY

CELLS WITH MULTIPLEXED INHIBITORY RNA

REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS